The news: Changes that limit how advertisers can target users with health-related ads on Meta’s social media platforms go into effect this month.
While ads are ubiquitous on Facebook and Instagram, Meta plans to slowly introduce ads on its Threads platform this year.
Here’s what the changes entail: Advertisers can no longer use certain health, financial, and political affiliation data collected by Meta for ad targeting purposes.
What’s driving the changes? Regulatory scrutiny over Meta’s practice of sharing health information with advertisers to help them target their ads.
Why it matters: Healthcare advertisers will no longer be able to use certain types of health-related data for targeting purposes, such as whether a user completed an online purchase of a prescription drug or product intended to treat a certain condition, per The Information.
With limited purchase data on hand, ad campaigns running on Meta’s platforms will be less targeted, and likely less effective. Advertisers will need to experiment with different approaches. This could include spreading ad budgets across a broader set of platforms or other digital channels to more effectively reach their target audiences.
The bigger picture: Healthcare advertisers will also need to contend with Meta’s recent decision to ditch its fact-checking program in favor of a community-based model for content moderation. The change means that advertisers will need to more strongly consider the potential brand safety risk since less restrictive content moderation policies could boost the spread of misinformation on Meta.
All told, the changes mean advertisers will have their work cut out for them to generate ad campaigns that both protect their brands’ reputation and help them break through to their intended audience.
This article is part of EMARKETER’s client-only subscription Briefings—daily newsletters authored by industry analysts who are experts in marketing, advertising, media, and tech trends. To help you finish 2024 strong, and start 2025 off on the right foot, articles like this one—delivering the latest news and insights—are completely free through January 31, 2025. If you want to learn how to get insights like these delivered to your inbox every day, and get access to our data-driven forecasts, reports, and industry benchmarks, schedule a demo with our sales team.